Expression and prognostic significance of livin/BIRC7 in childhood acute lymphoblastic leukemia

Medical Oncology

Volumn 31, Issue 5, 2014, Pages

  Ibrahim, Lamia ^a   Aladle, Doaa ^a   Mansour, Ahmed ^a   Hammad, Ayman ^a   Al Wakeel, Angi Adel ^a   Abd El Hameed, Suzy A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute lymphoblastic leukemia; Gene expression; Livin; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; LIVIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; BLOOD SAMPLING; BONE MARROW; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HOSPITALIZED CHILD; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84897291726     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0941-4     Document Type: Article

References (27)

1. Rana ZA, Rabbani MW, Sheikh MA, Khan AA. Outcome of childhood acute lymphoblastic leukemia after induction therapy 3 years experience at a single pediatric oncology centre. J Ayub Med Coll Abbottabad. 2009;21(4):150-3.
2. Wang PP, Haines C. Childhood and adolescent leukemia in a North American population. Int J Epidemiol. 1995;24(6):1100-9.
3. Reed CJ. Apoptosis and cancer: strategies for integrating programmed cell death. Semin Hematol. 2000;37:9-16.
4. Schimmer AD, Hedley DW, Penn LZ, Minden MD. Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood. 2001;98(13):3541-53.
5. Nachmias B, Ashhab Y, Ben-Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol. 2004;14:231-43. (Pubitemid 38824584)
6. Choi J, Hwang YK, SungKW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS. Expression of livin, an anti-apoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood. 2007;109(2):471-7. (Pubitemid 46105940)
7. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-IAP. A novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 2000;10(21):1359-66.
8. Crnkovic-Mertens I, Muley T, Meister M, Hartenstein B, Semzow J, Butz K, Hoppe-Seyler F. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells. Lung Cancer. 2006;54:135-42. (Pubitemid 44767539)
9. Nachmias B, Ashhab Y, Bucholtz V, Drize O, Kadouri L, Lotem M, Peretz T, Mandelboim O, Ben-Yehuda D. Caspase mediated cleavage converts livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res. 2003;63:6340-9. (Pubitemid 37255182)
10. Ma L, Huang Y, Song Z, Feng S, Tian X, Du W, Qiu X, Heese K, Wu M. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ. 2006;13(12):2079-88. (Pubitemid 44742691)
11. Kim DK, Alvarado CS, Abramowsky CR, Gu L, Zhou M, Soe MM, Sullivan K, George B, Schemankewitz E, Findley HW. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Pediatr Dev Pathol. 2005;8(6):621-9. (Pubitemid 41830922)
12. Holleman A, Den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood. 2003;102:4541-6. (Pubitemid 37494122)
13. Harms DO, Janka-Schaub GE. Cooperative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia. 2000;14:2234-9. (Pubitemid 32042264)
14. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR. TEL/AML1fusion resulting from a cryptic t (12; 21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 1995;9:1985-9. (Pubitemid 26023779)
15. Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem. 2001;276:3238-46.
16. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev. 1999;13:239-52. (Pubitemid 29095796)
17. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6:1796-803. (Pubitemid 30305074)
18. Yan B. Research progress on Livin protein: an inhibitor of apoptosis. Mol Cell Biochem. 2011;357(1-2):39-45.
19. Yang YL, Lin SR, Chen JS, Lin SW, Yu SL, Chen HY, Yen CT, Lin CY, Lin JF, Lin KH, Jou ST, Hu CY, Chang SK, Lu MY, Chang HH, Chang WH, Lin KS, Lin DT. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. Leuk Res. 2010;34(1):18-23.
20. El-Mesallamy HO, Hegab HM, Kamal AM. Expression of inhibitor of apoptosis protein (IAP) livin/BIRC7 in acute leukemia in adults: correlation with prognostic factors and outcome. Leuk Res. 2011;35(12):1616-22.
21. Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui C-H, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;110(4):1271-7. (Pubitemid 47281425)
22. Wuchter C, Richter S, Oltersdorf D, Karawajew L, Ludwig W, Tamm I. Differences in the expression pattern of apoptosis-related molecules between child-hood and adult de novo acute myeloid leukemia. Haematologica. 2004;89(3):363-4. (Pubitemid 38788426)
23. Coustan-Smith E, Kitanaka A, Pui C. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood. 1996;87:1140-6. (Pubitemid 26043542)
24. Campos L, Sabido O, Sebban C, Charrin C, Bertheas M, Fière D, et al. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia. Leukemia. 1996;10(3):434-8. (Pubitemid 26128781)
25. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. (Pubitemid 30046295)
26. Dohner K, Dohner H. Molecular characterization of acute myeloid leukemia. Haematologica. 2008;93(7):976-82. (Pubitemid 351957013)
27. Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 1997;90:2723-9.